Hongna Lai
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Comparison of Clinicopathological Features and Survival Between Distant Lymph Node Metastasis and Distant Micrometastasis in Breast Cancer.
Journal: Clinical breast cancer
Published: April 07, 2026
Clinical outcomes and genomic landscape of anti-HER2 antibody-drug conjugates in HER2-positive and HER2-low metastatic breast cancer.
Journal: Therapeutic advances in medical oncology
Published: March 28, 2026
Trastuzumab deruxtecan in an elderly patient with HR+/HER2-low breast cancer complicated by pleural effusion: a case report and literature review.
Journal: Frontiers in oncology
Published: October 24, 2025
Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer.
Journal: Cancer cell international
Published: February 16, 2025
Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system.
Journal: Frontiers in oncology
Published: August 13, 2023
HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer.
Journal: Oncology letters
Published: August 24, 2022
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.
Journal: Science China. Life sciences
Published: May 07, 2022
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.
Journal: Nature communications
Published: April 01, 2020
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy.
Journal: JCO precision oncology
Published: January 02, 2020
LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.
Journal: Science China. Life sciences
Published: May 09, 2019
Non-invasive analysis of tumor mutation profiles and druggable mutations by sequencing of cell free DNA of Chinese metastatic breast cancer patients.
Journal: Thoracic cancer
Published: December 17, 2018
Last Updated: 09/26/2026